Arctic Bioscience AS (OSL:ABS) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSL:ABS Arctic Bioscience AS OSL:ABS
52 GF Score
Price kr2.80
GF Value kr10.76
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Arctic Bioscience AS FFO per Share?

FFO per Share only applies to REITs.

OSL:ABS
52GF Score
Arctic Bioscience AS OSL:ABS
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Arctic Bioscience AS (OSL:ABS) Overvalued in 2026?

Based on GuruFocus' analysis, Arctic Bioscience AS stock appears to be undervalued. The current stock price of kr2.80 is trading 74% below its estimated GF Value™ of kr10.76. GuruFocus considers Arctic Bioscience AS to be Possible Value Trap.

Key valuation signals for OSL:ABS:

  • FFO per Share:
  • GF Value™: kr10.76 vs. price of kr2.80 (74% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the OSL:ABS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Arctic Bioscience AS Business Description

Other Exchanges 9TD:Germany
Address Industrivegen 42, Orsta, NOR, 6155
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. Geographically, the company operates in Norway, the Americas, Europe, and APAC, with the majority of the revenue derived from the Americas.
52GF Score

Get the complete analysis for OSL:ABS

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr2.80
Price
kr10.76
GF Value